GRANISETRON SANDOZ granisetron (as hydrochloride) 1 mg/1 mL concentrated injection vial

Land: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

granisetron hydrochloride, Quantity: 1.12 mg (Equivalent: granisetron, Qty 1 mg)

Fáanlegur frá:

Sandoz Pty Ltd

INN (Alþjóðlegt nafn):

granisetron hydrochloride

Lyfjaform:

Injection, solution

Samsetning:

Excipient Ingredients: sodium chloride; citric acid monohydrate; sodium hydroxide; hydrochloric acid; water for injections

Stjórnsýsluleið:

Intravenous

Einingar í pakka:

1 x 1 mL vial, 5 x 1 mL vials

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

Adults: Granisetron Sandoz injection is indicated for use in adults for: - the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy; - the prevention of nausea and vomiting induced by radiotherapy. Children: Granisetron Sandoz injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

Vörulýsing:

Visual Identification: clear, colourless to slightly yellow solution, free from visible particulates; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Leyfisstaða:

Registered

Leyfisdagur:

2011-10-25